Posted by Michael Wonder on 03 Jan 2024
MHRA’s new international recognition procedure goes live from 1 January 2024
2 January 2024 - In partnership with other global regulators, the international recognition procedure is expected to further help bring life-saving new medicines to UK patients.
From 1 January 2024, developers of new medicines can now submit applications via the MHRA’s new, international recognition procedure.
